Mechanistic and Functional Shades of Mucins and Associated Glycans in Colon Cancer
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Mucus serves as the chief protective barrier against pathogenic and mechanical insults in respiratory, gastrointestinal, and urogenital tracts. Altered mucin expression, the major component of mucus, in conjunction with differential glycosylation has been strongly associated with both benign and malignant pathologies of colon. Mucins and their associated glycans arbitrate their impact sterically as well as mechanically by altering molecular and microbial spectrum during pathogenesis. Mucin expression in normal and pathological conditions is regulated by nonspecific (dietary factors and gut microbiota) and specific (epigenetic and transcriptional) modulators. Further, recent studies highlight the impact of altering mucin glycome (cancer-associated carbohydrate antigens including Tn, Sialyl-Tn, Sialyl-Lew A, and Sialyl-Lewis X) on host immunomodulation, antitumor immunity, as well as gut microbiota. In light of emerging literature, the present review article digs into the impact of structural organization and of expressional and glycosylation alteration of mucin family members on benign and malignant pathologies of colorectal cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The consensus molecular subtypes of colorectal cancer
Guinney, J., Dienstmann, R., Wang, X., de Reyniès, A., Schlicker, A., Soneson, C., Marisa, L., Roepman, P., Nyamundanda, G., Angelino, P., et al. (2015) · Nature Medicine · doi:10.1038/nm.3967 · Cited by 5,170 · cited 1×
“Recently, CRC was divided into four consensus molecular subtypes (CMSs) with CMS1: hypermutated, MSI, and strong immune activation; CMS2: epithelial, marked WNT, and MYC signaling activation; CMS3: epithelial and evident metabolic dysregulation; and CMS4: prominent transforming growth factor beta (TGF) beta activation…”
BackgroundThe inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria
Johansson, M. E. V., Phillipson, M., Petersson, J., Velcich, A., Holm, L., & Hansson, G. C. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803124105 · Cited by 2,200 · cited 1×
“Gel-forming mucin MUC2 is secreted by goblet and columnar cells of gut epithelium and is organized into two layers [91].”
BackgroundVan der Sluis, M., De Koning, B. A. E., De Bruijn, A. C. J. M., Velcich, A., Meijerink, J. P. P., Van Goudoever, J. B., Büller, H. A., Dekker, J., Van Seuningen, I., Renes, I. B., et al. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.04.020 · Cited by 1,684 · cited 1×
“It is a critically important protective effect in the colon and has been demonstrated by utilizing MUC2-null mice that developed spontaneous colitis and adenomas leading to invasive adenocarcinoma [92,93].”
BackgroundSelectins and their ligands: Current concepts and controversies
Kansas, G. (1996) · Blood · doi:10.1182/blood.v88.9.3259.bloodjournal8893259 · Cited by 1,415
The genetics and immunopathogenesis of inflammatory bowel disease
Cho, J. H. (2008) · Nature Reviews Immunology · doi:10.1038/nri2340 · Cited by 940 · cited 2×
“These diseases also differ in other respects; CD tends to be transmural (involving the entire gut wall), while UC only involves the mucosa and submucosa [66].”
BackgroundColorectal Cancer in Mice Genetically Deficient in the Mucin Muc2
Velcich, A., Yang, W., Heyer, J., Fragale, A., Nicholas, C., Viani, S., Kucherlapati, R., Lipkin, M., Yang, K., & Augenlicht, L. (2002) · Science · doi:10.1126/science.1069094 · Cited by 936 · cited 1×
“It is a critically important protective effect in the colon and has been demonstrated by utilizing MUC2-null mice that developed spontaneous colitis and adenomas leading to invasive adenocarcinoma [92,93].”
BackgroundBurger-van Paassen, N., Vincent, A., Puiman, P. J., van der Sluis, M., Bouma, J., Boehm, G., van Goudoever, J. B., van Seuningen, I., & Renes, I. B. (2009) · Biochemical Journal · doi:10.1042/bj20082222 · Cited by 611
Lan, A., Andriamihaja, M., Blouin, J.-M., Liu, X., Descatoire, V., Desclée de Maredsous, C., Davila, A.-M., Walker, F., Tomé, D., & Blachier, F. (2015) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2014.09.007 · Cited by 57 · cited 1×
“In a study, rats fed with a high protein (53%) diet displayed an increased goblet cell concentration in the colonic crypt concomitant with decreased goblet cells at the epithelial surface as well as an increase in Muc3 mucin expression [65].”
Background
Cited by
The immune interactions of gut glycans and microbiota in health and disease
(2024) · doi:10.1111/mmi.15267 · Cited by 14
Bhirud, D., Bhattacharya, S., & Prajapati, B. G. (2024) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.37732 · Cited by 7
Yingli, H., Ping, Y., Jun, Y., & Xingwang, Z. (2025) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2025.167853 · Cited by 7
Metadata
- Authors
- Pothuraju, R., Krishn, S. R., Gautam, S. K., Pai, P., Ganguly, K., Chaudhary, S., Rachagani, S., Kaur, S., & Batra, S. K.
- Venue
- Cancers
- Publisher
- MDPI AG
- Published
- 2020-03-11
- Volume
- 12
- Issue
- 3
- Pages
- 649
- ISSN
- 2072-6694 (ISSN-L)
- OpenAlex
- W3010667590
- Cited by
- 62
- References
- 8
- FWCI
- 2.63
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Mechanistic and Functional Shades of Mucins and Associated Glycans in Colon Cancer. https://app.cochat.ai/papers/10.3390/cancers12030649
- The paper
- Pothuraju, R., Krishn, S. R., Gautam, S. K., Pai, P., Ganguly, K., Chaudhary, S., Rachagani, S., Kaur, S., & Batra, S. K. (2020). Mechanistic and Functional Shades of Mucins and Associated Glycans in Colon Cancer. Cancers. https://doi.org/10.3390/cancers12030649
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.